Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus plantarum 299v and Improved Quality of Life

Research synthesisLow evidenceMixed effect size4 studies · 3 beneficial · 1 neutral · 0 harmful

Based on 4 studies (3 beneficial, 1 neutral), Lactobacillus plantarum 299v shows moderate evidence for improving quality of life, with effect sizes ranging from small to large. Two of the 4 studies reported statistically significant findings, and the median study duration was 84 days. Most studies used doses around 1×10^10 CFU daily in clinical populations such as patients with Hashimoto's thyroiditis, irritable bowel syndrome, and cancer receiving home enteral nutrition.

  • Effective dose range: 1×10^10 CFU/day
  • Studied populations: Patients with Hashimoto's thyroiditis, irritable bowel syndrome, and cancer receiving home enteral nutrition

Caveats: Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive (3 of 4 studies beneficial) — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). One well-controlled RCT showed a neutral effect, suggesting the benefit may not be universal across all populations or dosing regimens.

Generated Jul 17, 2026
Doses used in studies
  • CFU/day: 10 billion–20 billion (median 15 billion, IQR 12.5 billion17.5 billion) 2 studies
Time to effect
Median: 2.8 months · IQR 2.8 months2.8 months · Range 2.8 months2.8 months — Reported in 1 of 4 studies
Safety in these studies
4 of 4 papers
Back to top